October 5-6, 2011
London
C5
C5’s 21st Forum on Biotech Patenting brings together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert legal advisors from a range of European, U.S. and emerging market jurisdictions. Finnegan's Elizabeth Doherty will present “How to Navigate through Antibody Claims and Personalized Medicine/Biomarkers in the U.S.” The conference will be held at the Sheraton Park Lane Hotel in London, England. For more information, or to register, please see C5’s website.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.